Systematic Review of Randomized Controlled Trials Evaluating Glycemic Efficacy and Patient Satisfaction of Intermittent-Scanned Continuous Glucose Monitoring in Patients with Diabetes
Authors:
- 27 April 2020
- journal article
- review article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 22 (5) , 337-345
Abstract
Introduction: Intermittent-scanned continuous glucose monitoring (isCGM) has the ability to allow for greater personalization of diabetes self-management. The purpose of this systematic review is to provide an updated analysis of the efficacy and patient satisfaction of isCGM in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). Methods: A research librarian searched PubMed, EMBASE, and Cochrane Library using keywords and subject headings to identify studies assessing efficacy and use of isCGMs in patients with T1DM and T2DM. Results: Nine randomized controlled trials (RCTs) involving patients with T1DM and T2DM using isCGM were included. Based on available RCT evidence investigating isCGM in patients with diabetes, isCGM may lead to a small decrease hemoglobin A1c (HbA1c) in certain subgroups of patients with uncontrolled T2DM (those using multiple daily insulin injections and aged 65 years or younger). Patients with uncontrolled T1DM using insulin may also benefit from isCGM, when combined with a structured diabetes education program. Evidence is mixed regarding isCGM impact on improving time in glycemic range, glycemic variability, and hypoglycemia. isCGM has demonstrated greater patient satisfaction and lower diabetes distress compared with usual care. Conclusions: isCGM may lead to improvements in HbA1c in certain subgroups of patients. Additional benefit with isCGM on time in glycemic range, glycemic variability, and hypoglycemia is unclear at this time. Future clinical trials are warranted to investigate the role of isCGM in patients with uncontrolled T2DM using insulin and oral antidiabetic drugs.Keywords
This publication has 22 references indexed in Scilit:
- Impact of technology on glycaemic control in type 2 diabetes: A meta‐analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusionDiabetes, Obesity and Metabolism, 2019
- Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled TrialsJournal of Diabetes Research, 2019
- Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical PracticeThe Diabetes Educator, 2018
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2019Diabetes Care, 2018
- 7. Diabetes Technology: Standards of Medical Care in Diabetes—2019Diabetes Care, 2018
- The Effectiveness of Continuous Glucose Monitoring in Patients with Type 2 Diabetes: A Systematic Review of Literature and Meta-analysisDiabetes Technology & Therapeutics, 2018
- Flash forward: a review of flash glucose monitoringDiabetic Medicine, 2018
- De-duplication of database search results for systematic reviews in EndNoteJournal of the Medical Library Association, 2016
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetesPediatric Diabetes, 2011